Literature DB >> 482586

The spectrum of hepatic dysfunction in inflammatory bowel disease.

M J Dew, H Thompson, R N Allan.   

Abstract

The spectrum and incidence of liver disease is described among a large series of patients with inflammatory bowel disease. The incidence of significant liver disease identified by the presence of serial biochemical abnormalities of liver function was 8.2 per cent. Transient peri-operative changes in liver function tests are common and usually relate to underlying intra-abdominal sepsis. Percholangitis, sometimes termed portal triaditis, is one of the commoner lesions, and is usually associated with extensive colitis and improves with resection of the underlying bowel disease. Cirrhosis of the liver is an important but uncommon complication and is usually associated with extensive long-standing disease. Stenosing cholangitis and biliary tract carcinoma are both important though rare associations. They are both associated with extensive disease of long-standing, but resection of the underlying inflammatory bowel disease does not necessarily protect the individual from these complications. Although stenosing cholangitis is a diffuse lesion of the biliary tree it is important to exclude strictures of the extra-hepatic biliary tree which may be amenable to surgical correction. Hepatic dysfunction is rarely the sole indication for advising surgery for the underlying bowel disease but the identification of the nature of the hepati- dysfunction provides a rational basis for such a decision and opportunities for the surgical correction of the hepatic lesion itself.

Entities:  

Mesh:

Year:  1979        PMID: 482586

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  14 in total

Review 1.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

2.  Long-standing asymptomatic primary sclerosing cholangitis: report of three cases.

Authors:  R W Chapman; A K Burroughs; N M Bass; S Sherlock
Journal:  Dig Dis Sci       Date:  1981-09       Impact factor: 3.199

3.  Liver dysfunction in inflammatory bowel disease.

Authors: 
Journal:  Br Med J       Date:  1979-09-22

4.  Splenic abscess. A rare complication of Crohn's colitis.

Authors:  D G Wechter; R A Willson
Journal:  Dig Dis Sci       Date:  1985-08       Impact factor: 3.199

5.  Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm.

Authors:  U Broomé; H Glaumann; G Hellers; B Nilsson; J Sörstad; R Hultcrantz
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

6.  Therapeutic investigations in primary sclerosing cholangitis.

Authors:  R Grijm; K Huibregtse; J Bartelsman; E M Mathus-Vliegen; W Dekker; G N Tytgat
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

7.  Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests.

Authors:  U Broomé; H Glaumann; R Hultcrantz
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

Review 8.  Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature.

Authors:  S H Mir-Madjlessi; R G Farmer; M V Sivak
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

9.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

10.  Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies.

Authors:  R P Anderson; T J Butt; V S Chadwick
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.